CN(Cc1ccccc1)c1ccc(C(CC(N)=O)NC(=O)Cc2ccc(Br)cc2)cc1[N+](=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?